A detailed history of Advance Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Advance Capital Management, Inc. holds 2,410 shares of ABT stock, worth $249,965. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,410
Previous 2,434 0.99%
Holding current value
$249,965
Previous $276,000 9.42%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

SELL
$100.73 - $112.44 $2,417 - $2,698
-24 Reduced 0.99%
2,410 $250,000
Q1 2024

Apr 04, 2024

BUY
$109.52 - $120.96 $12,594 - $13,910
115 Added 4.96%
2,434 $276,000
Q4 2023

Jan 10, 2024

BUY
$90.19 - $110.4 $10,822 - $13,248
120 Added 5.46%
2,319 $255,000
Q3 2023

Oct 13, 2023

BUY
$95.53 - $114.62 $6,878 - $8,252
72 Added 3.39%
2,199 $212,000
Q2 2023

Jul 03, 2023

BUY
$100.78 - $112.29 $214,359 - $238,840
2,127 New
2,127 $231,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Advance Capital Management, Inc. Portfolio

Follow Advance Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advance Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advance Capital Management, Inc. with notifications on news.